04:55 PM EST, 11/13/2025 (MT Newswires) -- Profound Medical ( PROF ) was last seen 4.9% in after-hours New York trade after the company on Thursday reported a narrower third-quarter loss as revenue advanced, with both measures beating forecasts.

The medical-device company said it lost US$8 million, or US$0.26 per share, in the quarter, compared to a loss of US$9.4 million, or US$0.38, in the prior year period. Analysts polled by FactSet had expected a loss of US$0.37 per share.

Revenue jumped 87% to a record US$5.3 million over the same period, beating the US$5 million FactSet forecast.

Profound said its Tulsa-Pro installed base now stands at 70 and the company expects to reach at least 75 installs by the end of the year.

"As demonstrated by our strong revenue and TULSA Procedure volume growth, increased gross margin, improved bottom line, and rapidly expanding TULSA-PRO installed base, we were not only able to successfully navigate through an unusually challenging second quarter, but also delivered record results in Q3-2025," said chief executive Arun Menawat. He added that positive momentum has continued into the fourth quarter.

Profound shares were last seen down US$0.32 to US$6.10 after hours. They closed down $0.01 to $9.04 on the Toronto Stock Exchange.